Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.
Safety-related regulatory actions for biologicals approved in the United States and the European Union.
Safety and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic colorectal cancer.
